Episode 224 | Joseph Mocanu, Managing Partner at Verge HealthTech Fund | Rethinking Venture Capital & Achieving Global HealthTech Impact

Episode notes

In this episode, Duane Mancini reconnects with Joseph Mocanu, Managing Partner at Verge HealthTec Fund, for a follow-up to their insightful conversation in episode 103. Joseph shares the significant milestones Verge HealthTec Fund has achieved since their last discussion and offers a glimpse into what we can anticipate in the coming years. The conversation takes a critical look at the venture capital landscape, exploring what needs to change and addressing the often-broken feedback loop between startups and investors. We delve into the importance of developing technologies with a global impact, the strategic advantages of a global approach to collecting clinical data, and navigating the complexities of various healthcare systems across the world. Tune in for a thought-provoking discussion on the future of healthtech investment and innovation. Joseph Mocanu Verve HealthTech Fund Duane Mancini LinkedIn Project Medtech Website Project Medtech LinkedIn

• Episode 266 | Laura Corcoran, CEO & Founder of Dignity Care | Innovating Compassionate Solutions for Pregnancy Loss56 / 100
• Episode 265 | Dr. Malcolm Townes, Innovation Fund Manager at Washington University | Strategic Medtech Commercialization: Lessons from the Gap Fund51 / 100
• Episode 264 | Will Kaigler & Megan Shaw | From Innovation to Impact: Crafting Medtech Culture and Success in Pittsburgh45 / 100
• Episode 263 | Mark Domyahn, Partner at JD Lymon Group | Strategic Reimbursement Planning for Medtech Innovators
• Episode 262 | Huzaifah Salat, MD, Physician Executive | Pioneering Lung Cancer Diagnosis & Driving Clinical Insight in Healthcare Innovation